Hemant Surgical Board approved audited standalone and consolidated financial results for FY26 and half-year ended March 31, 2026.
Standalone net profit surged 128% to ₹18.23 crore on revenue of ₹230.99 crore for FY26, with basic EPS at ₹15.42.
Company raised ₹61.53 crore through equity shares and warrants, utilizing ₹46.64 crore for capex, working capital, and debt repayment.
Auditors issued unmodified opinions on both standalone and consolidated results, confirming compliance with accounting standards.